Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | RNASEL | Q05823 | 1/20 | 0.38 |
| ▸ | DYRK3 | O43781 | 3/20 | 0.36 |
| ▸ | WEE1 | P30291 | 1/20 | 0.35 |
| ▸ | DYRK1B | Q9Y463 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | GALR3 | O60755 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | IGF1R | P08069 | 1/20 | 0.34 |
| ▸ | TTK | P33981 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 2/20 | 0.34 |
| ▸ | CSNK1E | P49674 | 1/20 | 0.34 |
| ▸ | CLK1 | P49759 | 1/20 | 0.34 |
| ▸ | CLK2 | P49760 | 1/20 | 0.34 |
| ▸ | CLK3 | P49761 | 1/20 | 0.34 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.34 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.34 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL249815 | 1.00 | HPGD (0.41) | HPGDRNASELDYRK3WEE1DYRK1B | |
| SCHEMBL8510897 | 0.96 | HPGD (0.38) | HPGDRNASELDYRK3DYRK1BMEN1 | |
| SCHEMBL8510894 | 0.96 | HPGD (0.38) | HPGDRNASELDYRK3DYRK1BMEN1 | |
| SCHEMBL8511185 | 0.93 | MAPT (0.40) | HPGDRNASELDYRK1BMEN1POLB | |
| SCHEMBL8511177 | 0.93 | MAPT (0.40) | HPGDRNASELDYRK1BMEN1POLB | |
| SCHEMBL252658 | 0.89 | MAPT (0.40) | HPGDRNASELMEN1POLBKMT2A | |
| SCHEMBL252659 | 0.89 | MAPT (0.40) | HPGDRNASELMEN1POLBKMT2A | |
| SCHEMBL250167 | 0.89 | DYRK3 (0.43) | HPGDRNASELDYRK3DYRK1BMEN1 | |
| SCHEMBL250166 | 0.89 | DYRK3 (0.43) | HPGDRNASELDYRK3DYRK1BMEN1 | |
| SCHEMBL8514561 | 0.87 | SOS1 (0.37) | HPGDDYRK3MAPTRECQLNPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120135989-A1 | AZAINDOLE DERIVATIVE | CRYSTALGENOMICS, INC. (KR) | 2012-05-31 | — | — | US | claimed |
| US-20120135989-A1 | AZAINDOLE DERIVATIVE | CRYSTALGENOMICS, INC. (KR) | 2012-05-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120135989-A1 | AZAINDOLE DERIVATIVE | CDC7, CDCA2, CDC5L | HPGD 4159/4885RNASEL 2872/4885DYRK3 1263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.